Yes. As of October 2026, Waters Corporation (WAT) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 12.0% / 30% · (Cash+Inv) / Mkt Cap (36m) 1.39% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 12.0% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 1.39% / 33% · Receivables / Mkt Cap (36m) 3.43% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 12.0% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 1.39% / 33.33% · Receivables / Mkt Cap (24m) 3.43% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 21.2% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 2.78% / 33.33% · Receivables / Avg Assets (4Q) 7.69% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| FTSE | Debt / Total Assets 21.3% / 33.33% · (Cash+ST Inv) / Total Assets 2.46% / 33.33% · (Cash+Recv) / Total Assets 8.53% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
Yes. As of October 2026, Waters Corporation (WAT) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
Yes. Waters Corporation is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
Waters Corporation reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated October 3, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.
Waters Corporation (NYSE: WAT) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $44.2B. The Maz Rating grades it against the other companies in its sector.
Waters Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $449.81, Waters Corporation trades at 192.9x trailing earnings, 7.9x sales and 2.9x book value, with an EV/EBITDA of 43.8. Over the last twelve months it generated about $5.6B of revenue and $229M of net income. It runs a gross margin of 49.7%, an operating margin of 4.7% and a net margin of 1.8%. It shows return on equity of 0.8%, return on invested capital of 1.1% and a free cash flow yield of 0.7%. On the balance sheet: a debt-to-equity ratio of 0.36 and a current ratio of 1.89. Over the past 52 weeks the share price ranged from $282.77 to $483.33, with a beta of 1.15.
Waters Corporation does not currently pay a dividend.
37 Wall Street analyst ratings cover the stock: 19 Buy, 16 Hold and 2 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.